RU2734475C2 - Разделение энантиомеров 3-этилбицикло [3.2.0] гепт-3-ен-6-она - Google Patents

Разделение энантиомеров 3-этилбицикло [3.2.0] гепт-3-ен-6-она Download PDF

Info

Publication number
RU2734475C2
RU2734475C2 RU2017143338A RU2017143338A RU2734475C2 RU 2734475 C2 RU2734475 C2 RU 2734475C2 RU 2017143338 A RU2017143338 A RU 2017143338A RU 2017143338 A RU2017143338 A RU 2017143338A RU 2734475 C2 RU2734475 C2 RU 2734475C2
Authority
RU
Russia
Prior art keywords
compound
formula
mixture
formulas
optically active
Prior art date
Application number
RU2017143338A
Other languages
English (en)
Russian (ru)
Other versions
RU2017143338A3 (enExample
RU2017143338A (ru
Inventor
Ронан Ли Форд
Премджи МЕГАНИ
Original Assignee
Новассай Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новассай Са filed Critical Новассай Са
Publication of RU2017143338A publication Critical patent/RU2017143338A/ru
Publication of RU2017143338A3 publication Critical patent/RU2017143338A3/ru
Application granted granted Critical
Publication of RU2734475C2 publication Critical patent/RU2734475C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00—Formation or introduction of functional groups containing nitrogen
    • C07B43/02—Formation or introduction of functional groups containing nitrogen of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00—Formation or introduction of functional groups containing nitrogen
    • C07B43/08—Formation or introduction of functional groups containing nitrogen of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/02—Purification; Separation; Stabilisation; Use of additives by treatment giving rise to a chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/85—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to a chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/613—Unsaturated compounds containing a keto groups being part of a ring polycyclic
    • C07C49/617—Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system
    • C07C49/623—Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system having two rings
    • C07C49/627—Unsaturated compounds containing a keto groups being part of a ring polycyclic a keto group being part of a condensed ring system having two rings the condensed ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
RU2017143338A 2015-05-27 2016-02-02 Разделение энантиомеров 3-этилбицикло [3.2.0] гепт-3-ен-6-она RU2734475C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562167232P 2015-05-27 2015-05-27
US62/167,232 2015-05-27
PCT/EP2016/052176 WO2016146299A1 (en) 2015-05-27 2016-02-02 Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one

Publications (3)

Publication Number Publication Date
RU2017143338A RU2017143338A (ru) 2019-06-27
RU2017143338A3 RU2017143338A3 (enExample) 2019-07-17
RU2734475C2 true RU2734475C2 (ru) 2020-10-16

Family

ID=55404679

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017143338A RU2734475C2 (ru) 2015-05-27 2016-02-02 Разделение энантиомеров 3-этилбицикло [3.2.0] гепт-3-ен-6-она

Country Status (11)

Country Link
US (1) US10150723B2 (enExample)
EP (1) EP3303308B1 (enExample)
JP (1) JP6775009B2 (enExample)
KR (1) KR102598202B1 (enExample)
CN (1) CN107667097B (enExample)
AU (1) AU2016232606A1 (enExample)
BR (1) BR112017025135B1 (enExample)
CA (1) CA2986954C (enExample)
RU (1) RU2734475C2 (enExample)
WO (1) WO2016146299A1 (enExample)
ZA (1) ZA201708769B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114264751B (zh) * 2021-12-28 2024-02-27 江苏威凯尔医药科技有限公司 一种高效液相色谱法分离米洛巴林中间体及其对映异构体的方法
CN115745764B (zh) * 2022-12-08 2024-03-12 重庆华森制药股份有限公司 一种米洛巴林中间体的制备方法
WO2024134671A1 (en) * 2022-12-21 2024-06-27 Bhisaj Pharmaceuticals Pvt Ltd Preparation of 3-ethylbicyclo[3.2.0]hept-3-en-6-one
CN116903468B (zh) * 2023-07-14 2024-01-26 山东新时代药业有限公司 一种米洛巴林中间体的制备方法
CN117886708B (zh) * 2023-12-05 2026-06-30 浙江天宇药业股份有限公司 一种苯磺酸米洛巴林的合成方法
CN117924061B (zh) * 2024-01-17 2026-03-20 北京海步医药科技有限公司 一种3-烷基双环[3.2.0]庚-3-烯-6-酮的拆分方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU147182A1 (ru) * 1961-07-18 1961-11-30 Е.С. Жданович Способ расщеплени синтетического рацемического альфа-окси-бета1-бета-диметил-гамма-бутиролактона
US20140296569A1 (en) * 2011-12-15 2014-10-02 Daiichi Sankyo Company, Limited Optical Resolution Method for Bicyclic Compound Using Asymmetric Catalyst

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0074856A3 (en) * 1981-09-16 1984-02-01 Glaxo Group Limited Resolution of racemic bicycloheptenones
WO2010084798A1 (ja) * 2009-01-21 2010-07-29 第一三共株式会社 3環性化合物
WO2010110361A1 (ja) * 2009-03-26 2010-09-30 第一三共株式会社 二環性γ-アミノ酸誘導体の製造方法
BR112013031360B1 (pt) * 2011-06-08 2022-01-25 Daiichi Sankyo Company, Limited Método para produzir um composto
ES2649968T3 (es) 2011-06-08 2018-01-16 Daiichi Sankyo Company, Limited Procedimiento de producción de un compuesto bicíclico vía transposición de Claisen
WO2013089189A1 (ja) * 2011-12-16 2013-06-20 第一三共株式会社 ヒドロキシスルホン酸を経由する二環性化合物の光学分割方法
HUE033397T2 (en) * 2012-04-10 2017-12-28 Daiichi Sankyo Co Ltd A method for the optical separation of bicyclic compounds by an enzyme
JP2013245215A (ja) * 2012-05-29 2013-12-09 Daiichi Sankyo Co Ltd 不斉環化反応による光学活性二環性化合物の製造方法
JP6491213B2 (ja) 2013-12-18 2019-03-27 ノヴァッセイ エスエー 疼痛および他の障害の治療のためのガンマ−アミノ酪酸(gaba)類似体

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU147182A1 (ru) * 1961-07-18 1961-11-30 Е.С. Жданович Способ расщеплени синтетического рацемического альфа-окси-бета1-бета-диметил-гамма-бутиролактона
US20140296569A1 (en) * 2011-12-15 2014-10-02 Daiichi Sankyo Company, Limited Optical Resolution Method for Bicyclic Compound Using Asymmetric Catalyst

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Bisticha, A. et al. tert-Butyl esters of peptides as organocatalysts for the asymmetric aldol reaction. Tetrahedron: Asymmetry, 2015, 26(2-3), 102-108 *
Kanemitsu, T. et al. L-t-Leucine-Catalyzed Direct Asymmetric Aldol Reaction of Cyclic Ketones. European Journal of Organic Chemistry, 2011, 2011(5), 993-997. *
Kanemitsu, T. et al. L-t-Leucine-Catalyzed Direct Asymmetric Aldol Reaction of Cyclic Ketones. European Journal of Organic Chemistry, 2011, 2011(5), 993-997. Bisticha, A. et al. tert-Butyl esters of peptides as organocatalysts for the asymmetric aldol reaction. Tetrahedron: Asymmetry, 2015, 26(2-3), 102-108. Zhao, H.-W. et al. Design, Synthesis and Organocatalysis of 2,2′-Biphenol-Based Prolinamide Organocatalysts in the Asymmetric Direct Aldol Reaction in Water. Synlett, 2013, 24(20), 2743-2747. Okuyama, Y. et al. Organocatalytic activity of 4-hydroxy-prolinamide alcohol with different noncovalent coordination sites in asymmetric Michael and direct aldol reactions. Tetrahedron Letters, 2009, 50(2), 193-197. *
Okuyama, Y. et al. Organocatalytic activity of 4-hydroxy-prolinamide alcohol with different noncovalent coordination sites in asymmetric Michael and direct aldol reactions. Tetrahedron Letters, 2009, 50(2), 193-197. *
Zhao, H.-W. et al. Design, Synthesis and Organocatalysis of 2,2′-Biphenol-Based Prolinamide Organocatalysts in the Asymmetric Direct Aldol Reaction in Water. Synlett, 2013, 24(20), 2743-2747. *

Also Published As

Publication number Publication date
US10150723B2 (en) 2018-12-11
RU2017143338A3 (enExample) 2019-07-17
WO2016146299A1 (en) 2016-09-22
BR112017025135A2 (en) 2018-08-07
ZA201708769B (en) 2019-04-24
KR102598202B1 (ko) 2023-11-03
CN107667097B (zh) 2021-02-12
US20180134643A1 (en) 2018-05-17
RU2017143338A (ru) 2019-06-27
JP2018517768A (ja) 2018-07-05
KR20180036919A (ko) 2018-04-10
JP6775009B2 (ja) 2020-10-28
BR112017025135B1 (pt) 2023-01-17
CA2986954C (en) 2023-06-27
CA2986954A1 (en) 2016-09-22
AU2016232606A1 (en) 2017-12-07
CN107667097A (zh) 2018-02-06
EP3303308A1 (en) 2018-04-11
EP3303308B1 (en) 2019-10-09

Similar Documents

Publication Publication Date Title
EP3303308B1 (en) Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one
US10689327B2 (en) Prodrug amino acid derivative
RU2679407C1 (ru) Аналоги гамма-аминомасляной кислоты (гамк) для лечения боли и других заболеваний
JP7314494B2 (ja) アミノ酸誘導体のプロドラッグを含有する医薬
HK1260638B (en) Prodrug of amino acid derivative
HK1260638A1 (en) Prodrug of amino acid derivative